It's been more than a minute since Tesla went public, but the EV company was inescapable on TechCrunch this week. From layoffs to pricing changes and more, it was a week dyed deeply in Tesla colors so we had to chat through the latest. The team also dug into Cherub, which wants to connect investors and founders, Maven Ventures' consumer investing push, and touched on what Mercury is up to.
STAMFORD, Conn., April 19, 2024--ISG has launched a study examining providers of contact center CX services that address rapidly changing work models and improving digital CX.
WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the closing of an underwritten public offering of 2,472,581 shares of its voting common stock at a public offering price of $7.1300 per share, which was equal to the closing price of its voting common stock on the Nasd
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|